Conference Day 1
Tuesday, September 12th, 2017
- Discuss why adeno associated virus (AAV) is the leading vector of choice in the field of gene therapy.
- Analyse the effects of shear and concentration methods in promoting stable associations between virus’, DNA and proteins
- Examine the benefit of monolithic purification in increasing the speed of product capture, flow rates and column loading
- Highlight an exclusively monolithic purification platform that includes three chromatographic steps and is fully scalable and effective for all AAV serotypes evaluated to date